BR0215070A - Methods of treating bacterial infections in dogs and cats - Google Patents

Methods of treating bacterial infections in dogs and cats

Info

Publication number
BR0215070A
BR0215070A BR0215070-0A BR0215070A BR0215070A BR 0215070 A BR0215070 A BR 0215070A BR 0215070 A BR0215070 A BR 0215070A BR 0215070 A BR0215070 A BR 0215070A
Authority
BR
Brazil
Prior art keywords
dogs
cats
bacterial infections
methods
treating bacterial
Prior art date
Application number
BR0215070-0A
Other languages
Portuguese (pt)
Inventor
Simon Edward Blanchflower
Brian Scott Bronk
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0130694.3A external-priority patent/GB0130694D0/en
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0215070A publication Critical patent/BR0215070A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

"MéTODOS DE TRATAMENTO DE INFECçõES BACTERIANAS EM CãES E GATOS". A invenção aqui descrita relaciona-se com o tratamento de uma gama de infecções bacterianas em animais de companhia, em particular gatos e cães, com um derivado b-lactama, composto de Fórmula I: A invenção também é dirigida a composições farmacêuticas de um composto de Fórmula I."METHODS OF TREATMENT OF BACTERIAL INFECTIONS IN DOGS AND CATS". The invention described herein relates to the treatment of a range of bacterial infections in pets, in particular cats and dogs, with a b-lactam derivative, compound of Formula I: The invention is also directed to pharmaceutical compositions of a compound of Formula I.

BR0215070-0A 2001-12-21 2002-11-13 Methods of treating bacterial infections in dogs and cats BR0215070A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0130694.3A GB0130694D0 (en) 2001-12-21 2001-12-21 Treatment
US35996102P 2002-02-27 2002-02-27
US39893302P 2002-07-26 2002-07-26
PCT/IB2002/004741 WO2003053522A1 (en) 2001-12-21 2002-11-13 Methods of treating bacterial infections in dogs and cats

Publications (1)

Publication Number Publication Date
BR0215070A true BR0215070A (en) 2004-11-09

Family

ID=27256361

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0215070-0A BR0215070A (en) 2001-12-21 2002-11-13 Methods of treating bacterial infections in dogs and cats

Country Status (12)

Country Link
EP (1) EP1455900A1 (en)
JP (1) JP2005524611A (en)
CN (1) CN1606463A (en)
AR (1) AR037594A1 (en)
AU (1) AU2002348985A1 (en)
BR (1) BR0215070A (en)
CA (1) CA2470995A1 (en)
IL (1) IL162103A0 (en)
NO (1) NO20043008L (en)
PL (1) PL370624A1 (en)
TW (1) TW200301126A (en)
WO (1) WO2003053522A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2292122T3 (en) * 2004-04-22 2008-03-01 Pfizer Products Incorporated DISORDERED CEFOVECINE SODIUM SALT STABILIZATION PROCEDURE.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2121745T3 (en) * 1989-03-30 1998-12-16 Pfizer CEPHALOSPORINS AND THEIR APPROVALS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS.
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation

Also Published As

Publication number Publication date
AU2002348985A1 (en) 2003-07-09
TW200301126A (en) 2003-07-01
JP2005524611A (en) 2005-08-18
NO20043008L (en) 2004-09-01
CN1606463A (en) 2005-04-13
AR037594A1 (en) 2004-11-17
PL370624A1 (en) 2005-05-30
EP1455900A1 (en) 2004-09-15
CA2470995A1 (en) 2003-07-03
IL162103A0 (en) 2005-11-20
WO2003053522A1 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
CY1111951T1 (en) PAINYL-CARBOXAMID COMPOUNDS USEFUL FOR PANTS
BR0214736A (en) Compound and its pharmaceutically acceptable salts, pharmaceutical composition and method of treating humans or animals suffering from diseases or conditions
AR037595A1 (en) METHODS OF TREATMENT AND FORMULATIONS OF CEPHALOSPORINE
TR200001330T2 (en) Oxazolidinone derivatives and pharmaceutical compositions
HRP20050517B1 (en) N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
PT911331E (en) SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE
BR0015722A (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
CA2288341A1 (en) Erythropoietin in the treatment of domestic and livestock animals for anemia
CY1111900T1 (en) TREATMENT OF NEUROPATHIC PAIN WITH N-METHYL-D-ASPARATIC COMPETITIVE RECEPTORS (NMDA)
DE60124694D1 (en) IMPROVED LIPID COMPOSITIONS AND DERIVATIVES THEREOF OF 3-METHOXYBENZYLTHIUM NITROGEN
BR0215070A (en) Methods of treating bacterial infections in dogs and cats
BR9807187A (en) Carbapenem compound, its use and intermediate compound for the same
DE69827814D1 (en) 8a-AZALIDES AS ANTIMICROBIAL AGENTS
DE60202184D1 (en) 5- (Alkylidene-cycloalkyl) - and 5- (Alkylidenes-heterocyclyl) -pyrazoles
BR0204547A (en) 5-heteroatom-substituted pyrazoles
ATE230264T1 (en) MEDICAL COMPOSITIONS AGAINST HELICOBACTER PYLORI
BR0308734A (en) Compound, pharmaceutical composition, use of compound, and method for preventing or treating infection
GB0003234D0 (en) Method of treatment
BR0204551A (en) S-heterocycle pyrazoles
BR0007491A (en) Use of 3-isoxazolidinones and hydroxylamic acids to treat infections
EA200100768A1 (en) APPLICATION OF 3-ISOXASOZOLIDINONES AND HYDROXYAMINO ACIDS FOR THE TREATMENT OF INFECTIONS
BR0204429A (en) Heterocycle alkylsulfonyl pyrazols
BR0002260A (en) Methods and compositions for the treatment of age-related disorders in pet animals
BR9905749A (en) Erythropoietin in the treatment of anemia in domestic animals and livestock

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A4A, 5A,6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2034 DE 29/12/2009.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/545 (2006.01), A61P 31/04 (2006.01)